MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-10-0000244
Nixi Laboratories Private Limited - pharma in Nahan, Himachal Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹80.22 Cr
▲ 60% YoY
Net profit · FY 2025
₹1.93 Cr
Net margin 2.4%
EBITDA · FY 2025
₹7.4 Cr
EBITDA margin 9.2%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.9 Cr
Issued & subscribed
Open charges
₹17.67 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
29
Provident fund records
About Nixi Laboratories Private Limited
Data last updated:
Nixi Laboratories Private Limited is a private limited company based in Nahan, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24100HP2016PTC001167. Its GSTIN is 02AAFCN6734N1Z8 (Himachal Pradesh).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.9 Cr. It is led by directors including Gurudev Singh Raina (Whole-Time Director) and Harmanpreet Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mouja Ogli Kala Amb, Nahan, Himachal Pradesh, India – 173030.
As per the financials filed for FY 2025, the company reported a revenue of ₹80.22 Cr, a growth of 60% compared to the previous year. For the same year it recorded a net profit of ₹1.93 Cr (net margin 2.4%) and EBITDA of ₹7.4 Cr (EBITDA margin 9.2%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 139% over five years.
The company has about 29 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nixi. As per MCA filings, the company has open charges of ₹17.67 Cr on record. Court records list 12 cases involving the company, including 9 filed by the company and 3 filed against it; 3 cases are pending. The company has 5 deals on record (3 secondary share transfers, 2 rights issues); the latest was in May 2024. Its 7 peer companies in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Endoc Lifecare Private Limited with revenue of ₹80.74 Cr.
Nixi Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-10-0000244). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nixilaboratories.com.
Company details
CIN U24100HP2016PTC001167
Registration Number 001167
Incorporation Date 08 March 2016
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HP-10-0000244
Key People
Gurudev Singh Raina Whole-Time Director Harmanpreet Singh Director Paresh Shantilal Bagadia Director Recognitions & Rankings of Nixi Laboratories
Contact details
Nixi Laboratories Private Limited's registered office is in Nahan, Himachal Pradesh. Its website is nixilaboratories.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressMouja Ogli Kala Amb, Nahan, Himachal Pradesh, India – 173030
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nixi Laboratories Private Limited, buy the company report.
Comprehensive company report
Nixi Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Nixi Laboratories operates one associated brand: Nixi. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures liquid and dry injections for pharmaceutical contract services. | nixilaboratories.com |
Business activity
The main business activity of Nixi Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nixi Laboratories Private Limited, buy the company report.
Financials of Nixi Laboratories Private Limited
FY 2024 filings availableNixi Laboratories Private Limited reported revenue of ₹80.22 Cr (up 60% YoY) for FY 2025.
Revenue · FY 2025
₹80.22 Cr ▲ 60%
Net profit · FY 2025
₹1.93 Cr margin 2.4%
EBITDA · FY 2025
₹7.4 Cr margin 9.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 60%
3 years · compounded
▲ 8%
5 years · compounded
▲ 139%
EBITDA CAGR growth
1 year
▲ 63%
3 years · compounded
▲ 6%
5 years · compounded
▲ 87%
Revenue has grown at a compounded annual rate (CAGR) of 139% over five years, including 60% growth in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.4 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.93 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.2% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nixi Laboratories Private Limited, buy the company report.
Board of directors of Nixi Laboratories Private Limited
Nixi Laboratories has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harmanpreet Singh | Director | 08 Mar 2016 | 10 Years 7 Months | Current |
| Paresh Shantilal Bagadia Also directs: Costcon Healthcare LLP, Apexio Pharma Private Limited, Spark Alchemy Private Limited and 1 more | Director | 01 Mar 2021 | 5 Years 7 Months | Current |
| Aditya Gupta | Director | 01 Mar 2021 | 5 Years 7 Months | Current |
| Gurudev Singh Raina | Whole-Time Director | 29 Mar 2025 | 1 Years 6 Months | Current |
Peer comparison
Nixi Laboratories Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Endoc Lifecare Private Limited | ₹80.74 Cr (FY 2025) | -8.0% | Rajkot, Gujarat, India | |||
| Nikvin Healthcare (India) Private Limited | ₹80.65 Cr (FY 2025) | 42.0% | New Delhi, Delhi, India | |||
| Adroit Pharmaceuticals Private Limited | ₹80.51 Cr (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| Salud Care (India) Limited | ₹80.41 Cr (FY 2025) | 16.0% | Ahmedabad, Gujarat, India | |||
| Nixi Laboratories Private Limitedthis company | ₹80.22 Cr (FY 2025) | ₹1.93 Cr | 2.4% | 60.0% | 29 | Nahan, Himachal Pradesh, India |
| D M Pharma Private Limited | ₹79.75 Cr (FY 2025) | 25.0% | Chandigarh, India | |||
| Bharat Immunologicals and Biologicals Corporation Limited | ₹79.49 Cr (FY 2022) | -9.0% | Uttar Pradesh, India | |||
| Swiss Garniers Genexiaa Sciences Private Limited | ₹79.31 Cr (FY 2025) | -12.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Nixi Laboratories Private Limited, buy the company report.
Auditor
Nixi Laboratories Private Limited is audited by GUPTA & MALHOTRA for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA & MALHOTRA | FY 2024 | 017964N |
Shareholding
The shareholding of Nixi Laboratories Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nixi Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹17.67 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Aug 2025 | 101140079 | Hdfc Bank Limited | ₹27.72 Lakh | Open | |
| 30 Jul 2025 | 101169605 | Others | ₹2 Cr | Open | |
| 24 Nov 2017 | 100164692 | State Bank of India | ₹15.39 Cr | Open |
To see the full charge records of Nixi Laboratories Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Nixi Laboratories Private Limited has 5 deals on record (3 secondary share transfers, 2 rights issues); the latest was in May 2024.
Total deals
5
Secondary share transfers
3
Rights issues
2
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2024 | Rights issue | ₹3.96 Cr | Investors: 3 individuals |
| Oct 2022 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2020 | Rights issue | ₹6.84 Cr | Investors: 4 individuals |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Nixi Laboratories Private Limited has 12 court cases on record: 9 filed by Nixi Laboratories, 3 filed against it. 3 cases are pending and 9 are disposed.
Total cases
12
Filed by the company
9
Filed against the company
3
Pending
3
Disposed
9
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 3 | 3 |
| High courts | 3 | 0 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sirmaur, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against Suncure Lifescience Private Limited and 1 other | Pending |
| District court, Sirmaur, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against Medtabs Pharma Private Limited and 2 others | Disposed |
| District court, Sirmaur, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against Strathspey Labs Private Limited and 2 others | Disposed |
| District court, Sirmaur, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against Sriya Lifescience Private Limited and 2 others | Disposed |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (O)) | Filed against the company by State of Bihar Through Jitendra Kumar Sinha | Pending |
To see the full case history of Nixi Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nixi Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nixi Laboratories Private Limited has a workforce of 29 employees on its EPFO records as of Mar 05, 2025, across 1 active EPFO establishment.
Employee count
29
Active EPFO establishments
1
Employee growth
7.41%
GST
Nixi Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAFCN6734N1Z8 | Himachal Pradesh | Active | 25 Jul 2017 |
To see the full GST registrations and return filing status of Nixi Laboratories Private Limited, buy the company report.
Recent activity
Nixi Laboratories Private Limited has 6 board changes on record since 2016: 4 appointments and 2 cessations. The latest: Gurudev Singh Raina was appointed as Whole-Time Director on 29 Mar 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.28 Cr with Charge ID 101140079 was registered on 05 Aug 2025.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101169605 was registered on 30 Jul 2025.
Charges
A charge with State Bank Of India of Rs. 15.39 Cr registered on 24 Nov 2017 with Charge ID 100164692 was modified on 31 Mar 2025.
Appointed
Gurudev Singh Raina was appointed as Whole-Time Director.
AGM
Nixi Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Nixi Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Himachal Pradesh.
Appointed
Aditya Gupta was appointed as Director.
Appointed
Paresh Shantilal Bagadia was appointed as Director.
Ceased
Sanjeev Kumar ceased to be Director.
Ceased
Gopalakrishnam Venkatasubramanyam ceased to be Whole-Time Director.
Charges
A charge with State Bank Of India amounted to Rs. 15.39 Cr with Charge ID 100164692 was registered on 24 Nov 2017.
Appointed
Harmanpreet Singh was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Nixi Laboratories is an active private limited company based in Nahan, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 March 2016 (10+ years old) and is registered under CIN U24100HP2016PTC001167.
Nixi Laboratories has 4 current directors:
- Gurudev Singh Raina - Whole-Time Director
- Harmanpreet Singh - Director
- Paresh Shantilal Bagadia - Director
- Aditya Gupta - Director
The latest financial statements of Nixi Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Nixi Laboratories is 02AAFCN6734N1Z8, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Nixi Laboratories is U24100HP2016PTC001167. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nixi Laboratories has 12 court cases on record: 9 filed by the company and 3 filed against it. 3 are pending. Most are in the district courts.
Nixi Laboratories was incorporated on 08 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Nixi Laboratories has 5 deals on record (3 secondary share transfers, 2 rights issues); the latest was in May 2024.
The peers of Nixi Laboratories by revenue are Endoc Lifecare Private Limited, Nikvin Healthcare (India) Private Limited, Adroit Pharmaceuticals Private Limited, Salud Care (India) Limited, D M Pharma Private Limited and 2 more, all in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gurudev Singh Raina was appointed as Whole-Time Director on 29 Mar 2025. Aditya Gupta was appointed as Director on 01 Mar 2021. Paresh Shantilal Bagadia was appointed as Director on 01 Mar 2021. Nixi Laboratories has 6 board changes on record in total.
Yes, Nixi Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-10-0000244).